-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Upgrades Treace Medical Concepts to Buy, Raises Price Target to $6.5

Benzinga·11/09/2026 09:48:01
Diffusion vocale
Stifel analyst Rick Wise upgrades Treace Medical Concepts (NASDAQ:TMCI) from Hold to Buy and raises the price target from $4.5 to $6.5.